Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk-Reference-Cited by-同舟云学术

Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk

Published:2018-09-14 Issue:6 Volume:22 Page:641-652
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Mitchell Dominic,Guertin Jason R.,LeLorier Jacques

Funder

Genome Canada (CA) and Genome Quebec

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s40291-018-0356-6/fulltext.html

Reference71 articles.

1. Mohamad TN, All M, Faddah R. Primary and secondary prevention of coronary artery disease. In: Drugs and disease: cardiology. Medscape; 2017. https://emedicine.medscape.com/article/164214-overview. Accessed 24 Feb 2018.

2. Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29(2):151–67. https://doi.org/10.1016/j.cjca.2012.11.032.

3. Catalan VS, LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health. 2000;3(6):417–26. https://doi.org/10.1046/j.1524-4733.2000.36006.x.

4. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203–12. https://doi.org/10.1161/circulationaha.105.505636.

5. Guertin JR, Rahme E, LeLorier J. Use of continuous exposure variables when examining dose-dependent pharmacological effects—application to the association between exposure to higher statin doses and the incidence of diabetes. J Popul Ther Clin Pharmacol. 2017;24(1):5–15. https://doi.org/10.22374/1710-6222.24.1.1.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of statin-induced myopathy and perspectives for the future;Expert Opinion on Drug Safety;2020-04-13